Clinical Trials in Michigan

Showing 14541-14560 of 16,154 trials

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

NCT00909545

The primary purpose of this study is to establish a dosage of isradipine CR that is tolerable and demonstrates preliminary efficacy for utilization in future pivotal efficacy studies.

Parkinson Disease

Northwestern University99 participantsStarted Jul 2009

Sunnyvale, California, United States • New Haven, Connecticut, United States • Jacksonville, Florida, United States +17 more locations

COMPLETEDPhase 262 miles

S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

NCT00003908

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel plus carboplatin in treating patients who have metastatic or recurrent head and neck cancer.

Head and Neck Cancer

SWOG Cancer Research Network68 participantsStarted Nov 1999

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +82 more locations

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Find Trials by Condition in Michigan

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer

Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus

PinPointe FootLaser for the Treatment of Onychomycosis

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

Ultra-brief Intervention for Problem Drinkers

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Durom(R) Hip Resurfacing System Multicenter Trial

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer